GSK4425689

Unknown / undisclosed

Automated registry profile: compiled from public clinical-trial and regulatory records; not yet individually analyst-verified.

—no registered trials

Evidence outlook

No clinical trials on ClinicalTrials.gov

No clinical trial of this drug is registered on ClinicalTrials.gov, so there is nothing to grade. Studies run outside that registry are not tracked here.

How the evidence outlook works ↗

All registered studies

Every ClinicalTrials.gov study of this drug's own program. Studies backing a featured trial above are marked Featured; the rest aren't individually graded.

No registered studies found. Not yet ingested, or none registered.

Competitive landscape

This drug's own stage for Malaria: Stage not on record. Competitors below are sorted furthest-along first.

DrugStageModalityMechanismEvidence signalReported efficacygraded featured trials
GSK4425689: this drugStage not on recordUndisclosedCircumsporozoite protein (CSP)not yet gradedNo reviewed efficacy summary in this indication
Ganaplacide / LumefantrinePhase 3Small molecule—not yet gradedNo reviewed efficacy summary in this indication
CipargaminPhase 2Small moleculePfATP4not yet gradedNo reviewed efficacy summary in this indication
GSK3772701Phase 2Undisclosed—not yet gradedNo reviewed efficacy summary in this indication
GSK4024484Phase 1Undisclosed—not yet gradedNo reviewed efficacy summary in this indication
INE963
Phase 1(overall)
Small molecule—not yet gradedNo reviewed efficacy summary in this indication

Upcoming events

No upcoming readouts on record for this asset.